ICCC

ImmuCell Corporation

ICCC | $5.125 1.49% 1.46% 2.5K

(0.0% 1d) (-0.8% 1m) (1.7% 1y) (0.0% 2d) (0.0% 3d) (-0.4% 7d) (-70.37% volume)
Earnings Calendar:
Market Cap: $ 39,723,178
http://www.immucell.com
Sec Filling | Patents | 54 employees

(US) ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

acquisitions defense treatment

add to watch list Paper trade email alert is off

Press-releases

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
Published: 2024-04-09 (Crawled : 20:00) - globenewswire.com
ICCC | $5.125 1.49% 1.46% 2.5K

Health Technology

| -3.26% | O: 1.72% H: 0.75% C: -2.07%
sales

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
Published: 2024-02-27 (Crawled : 21:00) - globenewswire.com
ICCC | $5.125 1.49% 1.46% 2.5K

Health Technology

| -1.75% | O: 1.29% H: 1.15% C: 0.26%
year financial results

ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
Published: 2024-02-16 (Crawled : 14:30) - globenewswire.com
ICCC | $5.125 1.49% 1.46% 2.5K

Health Technology

| 0.57% | O: 5.15% H: 0.0% C: -2.46%
year financial results

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
Published: 2024-01-08 (Crawled : 21:00) - globenewswire.com
ICCC | $5.125 1.49% 1.46% 2.5K

Health Technology

| 5.43% | O: 0.42% H: 4.99% C: 4.57%
sales results

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
Published: 2023-11-13 (Crawled : 21:00) - globenewswire.com
ICCC | $5.125 1.49% 1.46% 2.5K

Health Technology

| -2.88% | O: 2.91% H: 0.72% C: -0.96%
financial results

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
Published: 2023-11-07 (Crawled : 17:00) - globenewswire.com
ICCC | $5.125 1.49% 1.46% 2.5K

Health Technology

| -3.63% | O: -1.53% H: 5.43% C: 5.43%
financial results

ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
Published: 2023-10-05 (Crawled : 20:00) - globenewswire.com
ICCC | $5.125 1.49% 1.46% 2.5K

Health Technology

| -3.63% | O: 0.76% H: 3.22% C: 3.21%
sales results

ImmuCell Announces Submission of CMC Technical Section to the FDA
Published: 2023-08-29 (Crawled : 12:00) - globenewswire.com
ICCC | $5.125 1.49% 1.46% 2.5K

Health Technology

| 11.48% | O: 0.44% H: 2.86% C: 2.2%
fda submission

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
Published: 2023-08-10 (Crawled : 20:00) - globenewswire.com
ICCC | $5.125 1.49% 1.46% 2.5K

Health Technology

| 0.6% | O: 1.59% H: 1.63% C: -1.96%
financial results

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
Published: 2023-08-07 (Crawled : 16:00) - globenewswire.com
ICCC | $5.125 1.49% 1.46% 2.5K

Health Technology

| -2.7% | O: -1.54% H: 1.96% C: -1.76%
financial results

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001213900-23-074246	4	2023-09-06	2023-09-06	Buy	D	3100	103606
0001213900-23-072079	4	2023-08-30	2023-06-28	Buy	A	15000	15000